Roles of herparan sulfate proteoglycan modulation in upper gastrointestinal and pancreatic cancers.
Recruiting
- Conditions
- C25.9C15.9Pancreas, unspecifiedOesophagus, unspecified
- Registration Number
- DRKS00029543
- Lead Sponsor
- niversitätsklinik für Allgemein- und Viszeralchirurgie, Klinikum Oldenburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
30 patients each with uppergastrointestinal or pancreatic cancer that have been treated in the general and visceral surgery at Klinikum Oldenburg within the last 5 years
Exclusion Criteria
Patients who are not able to give their consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FFPE (tumor vs healthy tissue) samples from patients with upper gastrointestinal cancer or pancreatic cancer will be analyzed for HSPG metabolism using immunofluorescence microscopy, nanostring analysis, and WB.
- Secondary Outcome Measures
Name Time Method